A Better Model for Parkinson's Wednesday, February 03, 2016 Scientists at EPFL solve a longstanding problem with modeling Parkinson’s disease in animals. Using newfound insights, they improve both cell and animal models for the disease, which can propel research and drug development.Teva, AbCellera Launch Collaboration Wednesday, February 03, 2016 Agreement further supports Teva’s novel biologics development program.AbCellera, Merck Launch Collaboration Friday, January 29, 2016 AbCellera’s single cell antibody discovery technology unlocks the power of natural immunity. Faster Drug Discovery? Friday, January 29, 2016 Startup develops more cost-effective test for assessing how cells respond to chemicals.Avera, Epic Sciences Collaborate Friday, January 29, 2016 Epic Sciences, Inc. and Avera Medical Group have announced a collaboration on feasibility studies to better understand the effectiveness of personalized cancer treatments as part of novel ovarian and breast cancer clinical trials.Axol Bioscience Announces Chas Bountra as Scientific Advisory Board Member Friday, January 29, 2016 World leading pioneer on drug discovery through open innovation, joins the stem cell disease model specialists.Microalgae Make a Splash in the UK Cosmeceutical Market Friday, January 29, 2016 Scottish innovators have discovered an anti-viral and anti-inflammatory carbohydrate in microscopic algae (microalgae) which has huge potential to change the cosmetics market. Trillium Acquires Fluorinov Thursday, January 28, 2016 Trillium Therapeutics Inc. a clinical immuno-oncology company developing innovative therapies for the treatment of cancer, has announced that it has acquired all of the outstanding shares of Fluorinov Pharma Inc., a privately-held oncology company. ACD/Labs Celebrates 500th Customer in Asia & Pacific Region Thursday, January 28, 2016 ACD/Labs customers provide their unique perspectives on solutions deployed and used over the last decade.